2449. Validation of In Vitro Activity of Aminoglycosides Against Recently Isolated Helicobacter pylori for Commercialization of Gentamicin-Intercalated Smectite Hybrid as a New Therapeutic Agent

Open Forum Infect Dis · 2018 · PMC6254595

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

For commercial re-use, please contact journals.permissions@oup.com Abstract Background The eradication rate of Helicobacter pylori as a standard therapy based on amoxicillin and clarithromycin, exhibits a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.